During the past decade, Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 2 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust" #1 sponsor was "BeiGene" with 3 trials, followed by "Imperial College London" with 3 trials sponsored, "The Royal Bournemouth Hospital" with 3 trials sponsored, "Bournemouth University" with 2 trials sponsored and "Amsterdam UMC, location VUmc" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust" #1 collaborator was "Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust" with 3 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator, "Basingstoke and North Hampshire Hospital" with 1 trials as a collaborator, "Biocompatibles UK Ltd" with 1 trials as a collaborator and "Clinical Trials Sweden, Forum South" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust" are "Coronary Artery Disease" (2 trials), "Abdominal Aortic Aneurysm" (1 trials), "Arthroplasty, Replacement, Hip" (1 trials), "B-cell Malignancies" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust" in a lesser frequency.

Most popular intervention types in "Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust" are "Drug" (7 trials), "Procedure" (4 trials), "Other" (3 trials), "Device" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Zanubrutinib" (2 trials), "ACTr (Acceptance and Commitment Training)" (1 trials), "Attempt walking from 4 hours post operatively, on the day of their surgery." (1 trials), "BGB-3111" (1 trials) and "Bendamustine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".